Monolithisch India Limited (NSE:MONOLITH)

Market Cap	9.13B
Revenue (ttm)	973.44M
Net Income (ttm)	144.88M
Shares Out	21.74M
EPS (ttm)	9.11
PE Ratio	46.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	73,000
Average Volume	236,450
Open	418.65
Previous Close	418.65
Day's Range	406.00 - 427.90
52-Week Range	219.45 - 498.95
Beta	n/a
RSI	68.41
Earnings Date	n/a

About Blueprint Medicines

Monolithisch India Limited manufactures, trades in, and supplies ramming mass in India and Nepal. The company offers ramming mass used as a heat insulation/lining material by its customers as a refractory consumable for induction furnaces installed in iron/steel and foundry plants. It serves steel, metallurgy, and foundry industries. Monolithisch India Limited was incorporated in 2018 and is based in Ranchi, India. Monolithisch India Limited operates as a subsidiary of Kargil Transport Private Limited

• Industry: Industrial Inorganic Chemicals
• Founded: 2018
• Employees: 26
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MONOLITH

Financial Performance

In 2024, Monolithisch India's revenue was 973.44 million, an increase of 41.31% compared to the previous year's 688.87 million. Earnings were 144.88 million, an increase of 70.21%.